FDA Seeks Public Input on Testosterone Therapy for Men
December 11, 2025
December 11, 2025
WASHINGTON, Dec. 11 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration is asking the public and interested parties to submit information regarding testosterone replacement therapy (TRT) for men.
This request aims to gather perspectives to help inform the agency's considerations related to the treatment.
The announcement follows an expert panel discussion held on December 10, 2025, focused on the risks and benefits of male hormo . . .
This request aims to gather perspectives to help inform the agency's considerations related to the treatment.
The announcement follows an expert panel discussion held on December 10, 2025, focused on the risks and benefits of male hormo . . .